Davidson Kempner Capital Management’s Avalyn Pharma AVLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-23,000
Closed -$757K – 281
2026
Q2
$757K Buy
+23,000
New +$664K 0.01% 195

Other funds holding AVLN

Davidson Kempner Capital Management's AVLN Position: Q3 2026 in Review

Davidson Kempner Capital Management sold out of Avalyn Pharma (AVLN) in Q3 2026, closing a stake of 23,000 shares — an estimated $757K sold.

Davidson Kempner Capital Management first reported a position in AVLN in Q2 2026 and held it in 1 quarter. The position peaked at $757K in Q2 2026. 116 funds tracked by Wall St. Rank hold AVLN as of Q3 2026.

  • Davidson Kempner Capital Management reported no remaining Avalyn Pharma position as of Q3 2026 after selling out during the quarter.
  • Davidson Kempner Capital Management sold 23,000 Avalyn Pharma shares in Q3 2026, an estimated $757K.
  • Davidson Kempner Capital Management first reported a position in Avalyn Pharma in Q2 2026 and held it in 1 quarter.
  • Davidson Kempner Capital Management's Avalyn Pharma position peaked at $757K in Q2 2026.
  • 116 funds tracked by Wall St. Rank held Avalyn Pharma as of Q3 2026.

Based on Davidson Kempner Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.